Navigation Links
Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers
Date:10/14/2009

ct candidates will prove to be sufficiently safe and effective after introduction into a broader patient population; or that third parties on whom we depend will perform as anticipated.

Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof. 

          Copyright 2009 Cardium Therapeutics, Inc.  All rights reserved.
        For Terms of Use Privacy Policy, please visit www.cardiumthx.com.
         Cardium Therapeutics(TM) and Generx(R) are trademarks of Cardium
                                 Therapeutics, Inc.
      Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM), Excellagen(TM),
                          Excellarate(TM) and Osteorate(TM)
                     are trademarks of Tissue Repair Company.
       Regranex(R) and other trademarks are the property of their respective
                                      owners.

SOURCE Cardium Therapeutics


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Scientific Journal Gene Therapy Reports That Cardiums Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
2. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
3. Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
4. Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
5. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
6. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
7. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
8. Cardium Provides Update Regarding Exchange Listing Compliance Plan Accepted by NYSE Amex
9. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
10. Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
11. Cardiums Exchange Listing Compliance Plan Accepted by NYSE Alternext US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 AAG Health, the leading age ... today that it has acquired the OligoScan test made ... Using advanced spectrophotometry technology, the OligoScan device is capable ... to 14 heavy metals, 20 trace elements (minerals), and ... metal substances such as mercury, lead, aluminum, and arsenic, ...
(Date:5/21/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay ... of people with chronic obstructive pulmonary disease (COPD) ... older patients, a new large Canadian study reveals. ... 65 who are prescribed long-acting bronchodilators -- either ... Serevent). Both medications are commonly used to relieve ...
(Date:5/21/2013)... exist in the treatment of non-small cell lung cancer ... large new study. Although most patients with this ... researchers found that blacks were less likely than Hispanics ... of the disease. Hispanics were more likely to undergo ... white patients. "In our study of more than ...
(Date:5/21/2013)... negative effects of poorly controlled asthma symptoms on ... has been confirmed in a new study. ... sleep and school absences are important indicators of ... first to explore the associations between asthma, sleep ... using both objective and subjective measures," said ...
(Date:5/21/2013)... A novel approach to obstructing the runaway inflammatory ... shown promise in a Phase IIa clinical trial, ... will be presented at the American Thoracic Society ... the New England Journal of Medicine . ... efficacy and safety of the monoclonal antibody, dupilumab, ...
Breaking Medicine News(10 mins):Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 2Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 3Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 3Health News:Racial Disparities Seen in U.S. Lung Cancer Treatment 2Health News:Asthma symptoms impair sleep quality and school performance in children 2Health News:Monoclonal antibody appears effective and safe in asthma Phase IIa trial 2Health News:Monoclonal antibody appears effective and safe in asthma Phase IIa trial 3
... French . , Montreal, December 3rd, 2008 ... Dr. Robert Koenekoop from the Research Institute at the Montreal ... million from the Canadian Institutes of Health Research (CIHR) and ... fund an ambitious research project to develop innovative gene therapies ...
... instability in people with the blood disorder Fanconi anemia ... carcinomas linked to human papillomavirus (HPV), according to a ... . , Researchers led by Cincinnati Children,s Hospital Medical ... for the FA (Fanconi Anemia) gene complex triggers cellular ...
... Corporation (Nasdaq: HLTH ) announced today the final ... of its common stock at a price of $8.80 per share, ... 25, 2008. As previously announced, HLTH exercised its right to ... tender offer and has accepted for purchase 83,699,922 shares, including all ...
... Coalition for Pulmonary Fibrosis (CPF) today announced the launch of ... fighting pulmonary fibrosis (PF), a devastating and ultimately fatal disorder ... than 128,000 Americans. Prevalence and incidence of PF has ... 40,000 lives each year - the same number as breast ...
... in broccoli and cabbage works by lowering the activity ... according to a University of California, Berkeley, study appearing ... journal Proceedings of the National Academy of Sciences ... trials in humans because it was found to stop ...
... RICHMOND, Va., Dec. 3 Pernessa Seele,Founder/CEO of The Balm ... Kay and approximately 300 faith and community leaders at a,Civic ... recognizing,President George W. Bush and First Lady Laura Bush,s leadership ... It was in his first State of the ...
Cached Medicine News:Health News:CA$2.4 million toward gene therapy for human degenerative retinal diseases 2Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 2Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 3Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 4Health News:HLTH Corporation Announces Final Results of Its Tender Offer 2Health News:HLTH Corporation Announces Final Results of Its Tender Offer 3Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 2Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 3Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 4Health News:Broccoli compound targets key enzyme in late-stage cancer 2Health News:Broccoli compound targets key enzyme in late-stage cancer 3Health News:The Balm In Gilead Joins Saddleback Church in Thanking President Bush for His Leadership on Addressing HIV and AIDS Around the World 2
(Date:5/21/2013)... May 21, 2013  IsoRay, Inc. (AMEX: ... has entered into an exclusive international distribution agreement with ... line in Greece . IsoRay is ... and medical radioisotope applications for brain cancer, lung cancer, ... cancer. IASIS Medical is ideally suited ...
(Date:5/21/2013)... VIEW, Calif. , May 21, 2013 /PRNewswire/ ... design and manufacture of wireless personal healthcare products ... broaden its reach, announcing the release of two ... wireless blood pressure monitors and scales: the Wireless ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) ...
(Date:5/21/2013)... 21, 2013  The North Shore-LIJ Health System is ... hand-washing compliance at North Shore University Hospital in ... operating rooms at Forest Hills ... The new pilot program strengthens patient safety by ... (ORs), the first time in the US that remote ...
Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: